drugset / Trial / NCT01163643
Study to Assess the Safety and Efficacy of BOL-303242-X Ophthalmic Suspension in Dry Eye Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to identify the concentration and daily dosing frequency of BOL-303242-X ophthalmic suspension in treating dry eye syndrome over a 12 week dosing period.
Timeline
- Start
- 2010-07
- Primary completion
- 2011-06
- Completion
- 2011-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mapracorat | Small molecule | 0.3 % | Other |
| Subject | Mapracorat | Small molecule | 1 % | Other |
| Subject | Mapracorat | Small molecule | 2 % | Other |